We do it for you SPAC Finder Service
What We Will Do;
What We Will Do;
Reg A+ offerings - Anyone can invest |
|
Regulation A+ is an updated securities regulation that allows companies to raise up to $75 million from accredited and non-accredited investors worldwide and enables liquidity for insiders and investors, including Reg A+ NASDAQ and NYSE IPOs.
Most active Reg A+ offerings on Manhattan Street Capital
The Reg A Conference is the largest gathering of deal-makers, advisors, and companies interested in learning about using Regulation A to raise capital.
Use our promo code to save $200 - "REGA19MSC"
When InSitu Biologics, Inc. opened its Reg A+ pre-revenue equity offering to IRA investors in 2018, company President and CEO Jim Segermark quickly realized he was attracting new investors to the capital raise that wouldn’t have invested without the IRA option.
“All of our IRA investors have transferred in; no one has used new money to open their IRA account,” Segermark said. “We wouldn’t have gotten those investments if they hadn’t been able to use their IRA money.”
Join Rod Turner and three more expert speakers for an informal discussion about Regulation A+ (a new way for investors to invest in private companies) for an informal happy hour on March 15th in Los Angeles. Learn what makes Regulation A+ an attractive investment vehicle, legal implications, and more.
Register here for the 5 pm Happy Hour: Book Here Free
About this Event
I am pleased to announce two new offerings on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and update you on our platform's ongoing offerings.
My update to you on the latest changes in the live offerings on Manhattan Street Capital;
InSitu Biologics - AnestaGel™. Pausing soon*. Eliminate the need for addictive opiates for pain management after surgery.